Picture of Ambu A/S logo

AMBU B Ambu A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Brief: Ambu A/S Says Cost Reduction Program Will Correspond To A Reduction Of Approximately 200 Employees From Global Workforce; Revises FY Guidance

Aug 3 (Reuters) - Ambu A/S  AMBUb.CO :
    * REG-PRELIMINARY RESULTS FOR Q3 2021/22, CURRENT TRADING
(JULY)
AND LAUNCH OF COST REDUCTION PROGRAM. FULL-YEAR 2021/22 GUIDANCE
REVISED
    * FY 21/22 GUIDANCE REVISED TO ORGANIC REVENUE GROWTH OF NO
LESS
THAN 4% (PREVIOUSLY 13%+)
    * FY 21/22 GUIDANCE REVISED TO EBIT MARGIN BEFORE SPECIAL
ITEMS OF
NO LESS THAN 2% (PREVIOUSLY EBIT MARGIN 5%+).
    * Q3 REVENUE WAS DKK 1,128M (DKK 973M) BASED ON ORGANIC
GROWTH OF
8% (7%); REPORTED GROWTH WAS 16% (3%)
    * Q3 EBIT BEFORE SPECIAL ITEMS WAS AT DKK 42M (DKK 88M)
    * GROSS MARGIN FOR Q3 WAS 55.8% (62.5%); FOR FIRST NINE
MONTHS OF
YEAR, GROSS MARGIN WAS 58.2% (63.4%)
    * COST REDUCTION PROGRAM IS EXPECTED TO RESULT IN AN
ANNUALISED
IMPACT OF DKK 250M PRE-TAX SAVINGS FROM FINANCIAL YEAR 2022/23.
    * QTRLY EBIT AFTER SPECIAL ITEMS WAS AT DKK 29M (DKK 88M)
    * COST REDUCTION PROGRAM WILL CORRESPOND TO A REDUCTION OF
APPROXIMATELY 200 EMPLOYEES FROM OUR GLOBAL WORKFORCE

Source text for Eikon:  ID:nGNE6PgmmB 
Further company coverage:  AMBUb.CO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ambu A/S

See all news